2024-03-21 12:30:03 ET
Fennec Pharmaceuticals Inc. (FENC)
Q4 2023 Results Conference Call
March 21, 2024 08:30 AM ET
Company Participants
Robert Andrade - Chief Financial Officer
Rosty Raykov - Chief Executive Officer
Adrian Haigh - Chief Operating Officer
Conference Call Participants
Naureen Quibria - Capital One Securities
Chase Knickerbocker - Craig-Hallum
Dipesh Patel - H.C. Wainwright
Presentation
Operator
Good morning, ladies and gentlemen. And welcome to the Fennec Pharmaceuticals' Fourth Quarter and Full Year 2023 Earnings and Corporate Update Conference Call. At this time, all participants are in a listen only mode. Later we will conduct a question-and-answer session and instructions on how to participate will be given at that time. As a reminder, today's conference is being recorded. Now I would like to turn the conference over to Fennec's Chief Financial Officer, Robert Andrade. You may begin.
Robert Andrade
Thank you, operator. And good morning, everyone. We appreciate you joining us today for Fennec's Pharmaceuticals fourth quarter and full year 2023 earnings conference call, during which, we will review our financial results as well as provide a general business update. Joining me from Fennec this morning are Rosty Raykov, our Chief Executive Officer; and Adrian Haigh, our Chief Operating Officer. Before we begin, I would like to remind you that during this call, the company will be making forward-looking statements that are subject to risks and uncertainties that may cause actual results to differ from the results discussed in the forward-looking statements. References to these risks and uncertainties are made in today's press release and disclosed in detail in the company's periodic and current event filings with the US Securities and Exchange Commission. In addition, any forward-looking statements made on this call represent our views only as of today and should not be relied upon as representing our views as of any subsequent date. We specifically disclaim any obligation to update or revise any forward-looking statements. This conference call is being recorded for audio rebroadcast on Fennec Web site, www.fennecpharma.com, where it will be available for the next 30 days. And now I will turn the call over to Rosty Raykov. Rosty?...
Read the full article on Seeking Alpha
For further details see:
Fennec Pharmaceuticals Inc. (FENC) Q4 2023 Earnings Call Transcript